基于机器学习的冠状动脉疾病标志物:在两个纵向队列中的推导与验证
本研究利用95 935份电子健康记录开发并验证冠状动脉疾病预测机器学习模型,将预测概率作为ISCAD评分(范围0–1),在两个纵向生物库队列(BioMe 35 749人、UK Biobank 60 186人)中评估其与临床结局的关联。模型预测冠状动脉疾病的ROC曲线下面积在BioMe验证集为0.95(95%CI 0.94–0.95)、留出集为0.93(0.92–0.93),在UK Biobank外部测试集为0.91(0.91–0.91)。ISCAD捕捉了已知危险因素、汇总队列方程和多基因风险评分所包含的冠状动脉疾病风险;冠状动脉狭窄随ISCAD四分位数升高而定量增加(每四分位数增加12个百分点),全因死亡风险随ISCAD十分位数逐步升高(第1十分位HR 1.0,第6十分位HR 11,第10十分位HR 56)。高ISCAD(≥0.9)的未诊断个体中12人(46%)根据2014年美国心脏病学会/美国心脏协会工作组指南具有冠状动脉疾病的临床证据。
要点
- ISCAD评分范围0–1,由电子健康记录机器学习模型预测概率生成,可无创连续量化冠状动脉疾病。
- 模型预测冠状动脉疾病的AUC在BioMe验证集0.95(95%CI 0.94–0.95)、留出集0.93(0.92–0.93),UK Biobank外部测试集0.91(0.91–0.91)。
- 冠状动脉狭窄风险随ISCAD四分位数升高而增加,每升高一个四分位增加12个百分点。
- 全因死亡风险随ISCAD十分位数逐步升高:第1十分位HR 1.0、患病率0.2%;第6十分位HR 11(95%CI 3.9–31)、3.1%;第10十分位HR 56(95%CI 20–158)、11%。
- 高ISCAD(≥0.9)的未诊断个体中12人(46%)根据2014年美国心脏病学会/美国心脏协会工作组指南具有冠状动脉疾病的临床证据。
适用人群与场景
- BioMe Biobank队列35 749人,中位年龄61岁(IQR 18),男性14 599人(41%),女性21 150人(59%),已诊断冠状动脉疾病5130人(14%)。
- UK Biobank队列60 186人,中位年龄62岁(IQR 15),男性25 031人(42%),女性35 155人(58%),已诊断冠状动脉疾病8128人(14%)。
诊断标准与关键阈值
- ISCAD评分范围为0(最低概率)至1(最高概率),由机器学习模型预测冠状动脉疾病的概率生成。
- 高ISCAD定义为≥0.9。
研究设计与关键结果
- 研究类型为队列研究,利用95 935份电子健康记录开发并验证冠状动脉疾病预测机器学习模型,并在两个纵向生物库队列中评估ISCAD与临床结局的关联。
- 模型预测冠状动脉疾病的AUC在BioMe验证集为0.95(95%CI 0.94–0.95;敏感度0.94[0.94–0.95],特异度0.82[0.81–0.83]),在BioMe留出集为0.93(0.92–0.93;敏感度0.90[0.89–0.90],特异度0.88[0.87–0.88]),在UK Biobank外部测试集为0.91(0.91–0.91;敏感度0.84[0.83–0.84],特异度0.83[0.82–0.83])。
- ISCAD捕捉了已知危险因素、汇总队列方程和多基因风险评分所包含的冠状动脉疾病风险。
- 冠状动脉狭窄随ISCAD四分位数升高而定量增加(每四分位数增加12个百分点),包括阻塞性冠状动脉疾病、多支血管冠状动脉疾病和主要冠状动脉狭窄的风险。
- 全因死亡风险随ISCAD十分位数逐步升高:第1十分位HR 1.0(95%CI 1.0–1.0),患病率0.2%;第6十分位HR 11(95%CI 3.9–31),患病率3.1%;第10十分位HR 56(95%CI 20–158),患病率11%。
- 复发性心肌梗死也观察到类似趋势。
- 高ISCAD(≥0.9)的未诊断个体中12人(46%)根据2014年美国心脏病学会/美国心脏协会工作组指南具有冠状动脉疾病的临床证据。
证据类型、等级与局限
- 证据类型:队列研究(模型开发与验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基于电子健康记录的机器学习可生成ISCAD这一无创标志物,连续量化动脉粥样硬化及死亡风险,并识别诊断不足的个体。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Binary diagnosis of coronary artery disease does not preserve the complexity of disease or quantify its severity or its associated risk with death; hence, a quantitative marker of coronary artery disease is warranted. We evaluated a quantitative marker of coronary artery disease derived from probabilities of a machine learning model.
METHODS: In this cohort study, we developed and validated a coronary artery disease-predictive machine learning model using 95 935 electronic health records and assessed its probabilities as in-silico scores for coronary artery disease (ISCAD; range 0 [lowest probability] to 1 [highest probability]) in participants in two longitudinal biobank cohorts. We measured the association of ISCAD with clinical outcomes-namely, coronary artery stenosis, obstructive coronary artery disease, multivessel coronary artery disease, all-cause death, and coronary artery disease sequelae.
FINDINGS: Among 95 935 participants, 35 749 were from the BioMe Biobank (median age 61 years [IQR 18]; 14 599 [41%] were male and 21 150 [59%] were female; 5130 [14%] were with diagnosed coronary artery disease) and 60 186 were from the UK Biobank (median age 62 [15] years; 25 031 [42%] male and 35 155 [58%] female; 8128 [14%] with diagnosed coronary artery disease). The model predicted coronary artery disease with an area under the receiver operating characteristic curve of 0·95 (95% CI 0·94-0·95; sensitivity of 0·94 [0·94-0·95] and specificity of 0·82 [0·81-0·83]) and 0·93 (0·92-0·93; sensitivity of 0·90 [0·89-0·90] and specificity of 0·88 [0·87-0·88]) in the BioMe validation and holdout sets, respectively, and 0·91 (0·91-0·91; sensitivity of 0·84 [0·83-0·84] and specificity of 0·83 [0·82-0·83]) in the UK Biobank external test set. ISCAD captured coronary artery disease risk from known risk factors, pooled cohort equations, and polygenic risk scores. Coronary artery stenosis increased quantitatively with ascending ISCAD quartiles (increase per quartile of 12 percentage points), including risk of obstructive coronary artery disease, multivessel coronary artery disease, and stenosis of major coronary arteries. Hazard ratios (HRs) and prevalence of all-cause death increased stepwise over ISCAD deciles (decile 1: HR 1·0 [95% CI 1·0-1·0], 0·2% prevalence; decile 6: 11 [3·9-31], 3·1% prevalence; and decile 10: 56 [20-158], 11% prevalence). A similar trend was observed for recurrent myocardial infarction. 12 (46%) undiagnosed individuals with high ISCAD (≥0·9) had clinical evidence of coronary artery disease according to the 2014 American College of Cardiology/American Heart Association Task Force guidelines.
INTERPRETATION: Electronic health record-based machine learning was used to generate an in-silico marker for coronary artery disease that can non-invasively quantify atherosclerosis and risk of death on a continuous spectrum, and identify underdiagnosed individuals.
FUNDING: National Institutes of Health.
参考来源
- Forrest IS, Petrazzini BO, Duffy Á, et al. Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts. Lancet. 2022. PMID: 36563696. doi:10.1016/S0140-6736(22)02079-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。